Estar Medical strives to enrich the product portfolio by constantly investing in R&D. Our efforts continue to yield highly promising data and new intellectual property across a range of therapeutic areas.


The product pipeline is based on our unique Tropocells® System Platform and consists of the following products:


  • Novel PRP-based regenerative products combining PRP with a range of clinically & commercially valuable biologics, such as hyaluronic acid, collagen, bone substitutes
  • BMAC System for concentrating bone marrow aspirate-derived cells
  • Tropokine™ - System for autologous IL1-RA enrichment
  • Autologous biological glues
  • Autologous thrombin
  • PRP combined with other biologics